BlackRock’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
367,181
+14,990
| +4% | +$136K | ﹤0.01% | 3857 |
|
|
2025
Q1 | $3.36M | Sell |
352,191
-5,653
| -2% | -$53.9K | ﹤0.01% | 3759 |
|
|
2024
Q4 | $4.02M | Buy |
357,844
+7,700
| +2% | +$86.5K | ﹤0.01% | 3768 |
|
|
2024
Q3 | $5.03M | Buy |
350,144
+41,235
| +13% | +$593K | ﹤0.01% | 3647 |
|
|
2024
Q2 | $5.33M | Buy |
308,909
+252,450
| +447% | +$4.36M | ﹤0.01% | 3617 |
|
|
2024
Q1 | $1.13M | Sell |
56,459
-689
| -1% | -$13.7K | ﹤0.01% | 4111 |
|
|
2023
Q4 | $601K | Buy |
57,148
+1,158
| +2% | +$12.2K | ﹤0.01% | 4313 |
|
|
2023
Q3 | $495K | Sell |
55,990
-1,585
| -3% | -$14K | ﹤0.01% | 4361 |
|
|
2023
Q2 | $555K | Buy |
57,575
+823
| +1% | +$7.94K | ﹤0.01% | 4372 |
|
|
2023
Q1 | $783K | Buy |
56,752
+5,830
| +11% | +$80.4K | ﹤0.01% | 4323 |
|
|
2022
Q4 | $774K | Buy |
50,922
+111
| +0.2% | +$1.69K | ﹤0.01% | 4413 |
|
|
2022
Q3 | $462K | Sell |
50,811
-240
| -0.5% | -$2.18K | ﹤0.01% | 4664 |
|
|
2022
Q2 | $433K | Sell |
51,051
-185,204
| -78% | -$1.57M | ﹤0.01% | 4723 |
|
|
2022
Q1 | $4.64M | Sell |
236,255
-1,704
| -0.7% | -$33.4K | ﹤0.01% | 3928 |
|
|
2021
Q4 | $5.79M | Buy |
237,959
+20,105
| +9% | +$489K | ﹤0.01% | 3870 |
|
|
2021
Q3 | $8.51M | Buy |
217,854
+106
| +0% | +$4.14K | ﹤0.01% | 3688 |
|
|
2021
Q2 | $9.79M | Buy |
217,748
+154,208
| +243% | +$6.93M | ﹤0.01% | 3590 |
|
|
2021
Q1 | $2.17M | Buy |
63,540
+4,244
| +7% | +$145K | ﹤0.01% | 4202 |
|
|
2020
Q4 | $2.16M | Buy |
+59,296
| New | +$2.16M | ﹤0.01% | 3938 |
|